Trans-3′-hydroxycotinine O- and N-glucuronidations in human liver microsomes

Drug Metabolism and Disposition

Volumn 33, Issue 1, 2005, Pages 23-30

  Yamanaka, Hiroyuki ^a   Nakajima, Miki ^a   Katoh, Miki ^a   Kanoh, Ayano ^a   Tamura, Osamu ^a   Ishibashi, Hiroyuki ^a   Yokoi, Tsuyoshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3' HYDROXYCOTININE O GLUCURONIDE; ANDROSTANEDIOL; GLUCURONOSYLTRANSFERASE; IMIPRAMINE; NICOTINE DERIVATIVE; PROPOFOL; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GLUCURONIC ACID; VALPROIC ACID; COTININE; DRUG DERIVATIVE; GLUCURONIDE; HYDROXYCOTININE;

ARTICLE; BACULOVIRUS; CATALYSIS; CONTROLLED STUDY; DRUG GLUCURONIDATION; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; IC 50; INSECT CELL CULTURE; LIVER MICROSOME; LIVER MICROSOME METABOLISM; MICHAELIS CONSTANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN VARIANT; ANIMAL; CHEMISTRY; CONFORMATION; INSECT; METABOLISM; STEREOISOMERISM;

INSECTA; UNIDENTIFIED BACULOVIRUS;

ANIMALS; CARBOHYDRATE CONFORMATION; COTININE; GLUCURONIDES; HUMANS; INSECTS; MICROSOMES, LIVER; STEREOISOMERISM;

EID: 11144257101     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.104.001701     Document Type: Article

References (26)

1. Benowitz NL and Jacob P III (2001) Trans-3′-hydroxycotinine: disposition kinetics, effects and plasma levels during cigarette smoking. Br J Clin Pharmacol 51:53-59.
2. Benowitz NL, Jacob P III, Fong I, and Gupta S (1994) Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exp Ther 268:296-303.
3. Byrd GD, Chang KM, Greene JM, and deBethizy JD (1992) Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine and trans-3′-hydroxycotinine in smokers. Drug Metab Dispos 20:192-197.
4. Byrd GD, Uhrig MS, deBethizy JD, Caldwell WS, Crooks PA, Ravard A, and Riggs R (1994) Direct determination of cotinine-N-glucuronide in urine using thermospray liquid chromatography/mass spectrometry. Biol Mass Spectrom 23:103-107.
5. Coffman BL, Rios GR, King CD, and Tephly TR (1997) Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Dispos 25:1-4.
6. Ethell BT, Anderson GD, and Burchell B (2003) The effect of valproic acid on drug and steroid glucuronidation by expressed human UDP- glucuronosyltransferases. Biochem Pharmacol 65:1441-1449.
7. Ghoshen O and Hawes EM (2002) N-glucuronidation of nicotine and cotinine in human: formation of cotinine glucuronide in liver microsomes and lack of catalysis by 10 examined UDP-glucuronosyltransferases. Drug Metab Dispos 30:991-996.
8. Hanioka N, Ozawa S, Jinno H, Ando M, Saito Y, and Sawada J (2001) Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin. Xenobiotica 31:687-699.
9. Hiller A, Nghia N, Strassburg CP, Li Q, Jainta H, Pechstein B, Ruus P, Engel J, Tuley RH, and Kronbach T (1999) Retigabine N-glucuronidation and its potential role in enterohepatic circulation. Drug Metab Dispos 27:605-612.
10. Iwatsubo T, Hirota N, Ooie T, Suzuki H, Shimada N, Chiba K, Ishizaki T, Green CE, Tyson CA, and Sugiyama Y (1997) Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data. Pharmacol Ther 73:147-171.
11. Kuehl GE and Murphy SE (2003a) N-glucuronidation of nicotine and cotinine by human liver microsomes and heterologously expressed UDP- glucuronosyltransferases. Drug Metab Dispos 31:1361-1368.
12. Kuehl GE and Murphy SE (2003b) N-glucuronidation of trans-3′- hydroxycotinine by human liver microsomes. Chem Res Toxicol 16:1502-1506.
13. Lin JH and Wong BK (2002) Complexities of glucuronidation affecting in vitro-in vivo extrapolation. Curr Drug Metab 3:623-646.
14. Mano Y, Usui T, and Kamimura H (2004) In vitro inhibition and stimulation of β-estradiol and propofol on the 4-methylumbelliferone glucuronidation by recombinant human UGT isozymes 1A1, 1A8 and 1A9. Biopharm Drug Dispos 25:339-344.
15. McGurk KA, Brierley CH, and Burchell B (1998) Drug glucuronidation by human renal UDP-glucuronosyltransferases. Biochem Pharmacol 55:1005-1012.
16. Nakajima M, Tanaka E, Kobayashi T, Ohashi N, Kume T, and Yokoi T (2002a) Imipramine N-glucuronidations in human liver microsomes: biphasic kinetics and characterization of UDP-glucuronosyltransferase isoforms. Drug Metab Dispos 30:636-642.
17. Nakajima M, Tanaka E, Kwon JT, and Yokoi T (2002b) Characterization of nicotine and cotinine N-glucuronidations in human liver microsomes. Drug Metab Dispos 30:1484-1490.
18. Nakajima M, Yamamoto T, Nunoya K-I, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T, and Kuroiwa Y (1996a) Role of human cytochrome P450 2A6 in C-oxidation of nicotine. Drug Metab Dispos 24:1212-1217.
19. Nakajima M, Yamamoto T, Nunoya K-I, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T, and Kuroiwa Y (1996b) Characterization of CYP2A6 involved in 3′-hydroxylation of cotinine in human liver microsomes. J Pharmacol Exp Ther 277:1010-1015.
20. Nowell SA, Massengill JS, Williams S, Radominska-Pandya A, Tephly TR, Cheng Z, Strassburg CP, Tukey RH, MacLeod SL, Lang NP, et al. (1999) Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-6]pyridine by human microsomal UDP-glucuronosyltransferases: identification of specific UGT1A family isoforms involved. Carcinogenesis 20:1107-1114.
21. Radominska-Pandya A, Czernik PJ, and Little JM (1999) Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab Rev 31:817-899.
22. Ren Q, Murphy SE, and Lazarus P (2000) O-Glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by human UDP-glucuronosyltransferases 2B7 and 1A9. Drug Metab Dispos 28:1352-1360.
23. Turgeon D, Carrier JS, Levesque E, Hum DW, and Belanger A (2001) Relative enzymatic activity, protein stability and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology 142:778-787.
24. Wiener D, Doerge DR, Fang J-L, Upadhyaya P, and Lazarus P (2004) Characterization of N-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human liver: importance of UDP-glucuronosyltransferase 1A4. Drug Metab Dispos 32:72-79.
25. Williams JA, Ring BJ, Cantrell VE, Campanale K, Jones DR, Hall SD, and Wrighton SA (2002) Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes. Drug Metab Dispos 30:1266-1273.
26. Yamanaka H, Nakajima M, Nishimura K, Yoshida R, Fukami T, Katoh M, and Yokoi T (2004) Metabolic profile of nicotine in subjects whose CYP2A6 gene is deleted. Eur J Pharm Sci 22:419-425.